UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Protective Effects of Polyphenol-Rich Extracts against Neurotoxicity Elicited by Paraquat or Rotenone in Cellular Models of Parkinson's Disease

Antioxidants, 2023-07, Vol.12 (7), p.1463

2023

Volltextzugriff (PDF)

Yeast Reveal a "Druggable" Rsp5/Nedd4 Network that Ameliorates α-Synuclein Toxicity in Neurons

Science (American Association for the Advancement of Science), 2013-11, Vol.342 (6161), p.979-983

2013

Volltextzugriff (PDF)

A mutation map for human glycoside hydrolase genes

Glycobiology (Oxford), 2020-08, Vol.30 (8), p.500-515

2020

Volltextzugriff (PDF)

Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated Dysfunctions

Scientific reports, 2019-11, Vol.9 (1), p.16947-14, Article 16947

2019

Volltextzugriff (PDF)

Mutations in GET4 disrupt the transmembrane domain recognition complex pathway

Journal of inherited metabolic disease, 2020-09, Vol.43 (5), p.1037-1045

2020

Volltextzugriff (PDF)

2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is selectively toxic to primary dopaminergic neurons in vitro

Toxicological sciences, 2014-07, Vol.140 (1), p.179-189

2014

Volltextzugriff (PDF)

Neuroprotective effects of anthocyanin- and proanthocyanidin-rich extracts in cellular models of Parkinson׳s disease

Brain research, 2014-03, Vol.1555, p.60-77

2014

Volltextzugriff (PDF)

Mutations in GET4 disrupt the transmembrane domain recognition complex pathway

The FASEB journal, 2020-04, Vol.34 (S1), p.1-1

2020

Volltextzugriff (PDF)

2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Is Selectively Toxic to Primary Dopaminergic Neurons In Vitro

Toxicological sciences, 2014-10, Vol.141 (2), p.560-560

2014

Volltextzugriff (PDF)

Yeast Reveal a "Druggable" Rsp5/Nedd4 Network that Ameliorates [alpha]-Synuclein Toxicity in Neurons

Science (American Association for the Advancement of Science), 2013-11, Vol.342 (6161), p.979

2013

Volltextzugriff (PDF)

Neuroprotective effects of polyphenols in cellular models of Parkinson's disease

Tambe, Mitali A

2015

Volltextzugriff (PDF)

Successfully Navigating Food and Drug Administration Orphan Drug and Rare Pediatric Disease Designations for AAV9-hPCCA Gene Therapy: The National Institutes of Health Platform Vector Gene Therapy Experience

Human gene therapy, 2023-03, Vol.34 (5-6), p.217-227

2023

Volltextzugriff (PDF)

Chapter 18 - Dietary Phytochemicals in Neurodegenerative Disease

Nutrition in the Prevention and Treatment of Disease, 2017, p.361-391

Fourth Edition, 2017

Volltextzugriff (PDF)

In depth characterization of midbrain organoids derived from wild type iPSC lines

PloS one, 2023-10, Vol.18 (10), p.e0292926-e0292926

2023

Volltextzugriff (PDF)

Beyond ERAD: N‐glycanase will bring you to tears

The FASEB journal, 2018-04, Vol.32 (S1), p.673.4-673.4

2018

Volltextzugriff (PDF)

Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study

Journal of clinical oncology, 2023-01, Vol.41 (2), p.222-232

2023

Volltextzugriff (PDF)

Neuroprotective mechanisms of red clover and soy isoflavones in Parkinson's disease models

Food & function, 2021-11, Vol.12 (23), p.11987-127

2021

Volltextzugriff (PDF)

Identification of Potent ADCK3 Inhibitors through Structure-Based Virtual Screening

Journal of chemical information and modeling, 2024-08, Vol.64 (15), p.6072-6080

2024

Volltextzugriff (PDF)

Generation and characterization of NGLY1 patient-derived midbrain organoids

Frontiers in cell and developmental biology, 2023-02, Vol.11, p.1039182-1039182

2023

Volltextzugriff (PDF)

Phase 3 randomised study evaluating the addition of low-dose nivolumab to palliative chemotherapy in head and neck cancer

Journal of clinical oncology, 2022-06, Vol.40 (17_suppl), p.LBA6016-LBA6016

2022

Volltextzugriff (PDF)

A Dominant Heterozygous Mutation in COG4 Causes Saul-Wilson Syndrome, a Primordial Dwarfism, and Disrupts Zebrafish Development via Wnt Signaling

Frontiers in cell and developmental biology, 2021-09, Vol.9, p.720688-720688

2021

Volltextzugriff (PDF)

The role of conserved transmembrane domain residues in the activation of the dopamine D2 receptor

The FASEB journal, 2009-04, Vol.23 (S1)

2009

Volltextzugriff (PDF)

Pikuni-Blackfeet traditional medicine: Neuroprotective activities of medicinal plants used to treat Parkinson’s disease-related symptoms

Journal of ethnopharmacology, 2017-07, Vol.206, p.393-407

2017

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(23)

Publikationsform

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Plos One
(3)
The Faseb Journal
(3)
Frontiers In Cell And Developmental Biology
(2)
Journal Of Clinical Oncology
(2)
Science
(2)
Toxicological Sciences
(2)
Antioxidants
(1)
Brain Research
(1)
Food & Function
(1)
Glycobiology
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease

Protective Effects of Polyphenol-Rich Extracts against Neurotoxicity Elicited by Paraquat or Rotenone in Cellular Models of Parkinson's Disease

Yeast Reveal a "Druggable" Rsp5/Nedd4 Network that Ameliorates α-Synuclein Toxicity in Neurons

Targeting the Intrinsically Disordered Structural Ensemble of [alpha]-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson's Disease

A mutation map for human glycoside hydrolase genes

Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated Dysfunctions

Mutations in GET4 disrupt the transmembrane domain recognition complex pathway

2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is selectively toxic to primary dopaminergic neurons in vitro

Neuroprotective effects of anthocyanin- and proanthocyanidin-rich extracts in cellular models of Parkinson׳s disease

Mutations in GET4 disrupt the transmembrane domain recognition complex pathway

2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Is Selectively Toxic to Primary Dopaminergic Neurons In Vitro

Yeast Reveal a "Druggable" Rsp5/Nedd4 Network that Ameliorates [alpha]-Synuclein Toxicity in Neurons

Neuroprotective effects of polyphenols in cellular models of Parkinson's disease

Successfully Navigating Food and Drug Administration Orphan Drug and Rare Pediatric Disease Designations for AAV9-hPCCA Gene Therapy: The National Institutes of Health Platform Vector Gene Therapy Experience

Chapter 18 - Dietary Phytochemicals in Neurodegenerative Disease

In depth characterization of midbrain organoids derived from wild type iPSC lines

Beyond ERAD: N‐glycanase will bring you to tears

Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study

Neuroprotective mechanisms of red clover and soy isoflavones in Parkinson's disease models

Identification of Potent ADCK3 Inhibitors through Structure-Based Virtual Screening

Generation and characterization of NGLY1 patient-derived midbrain organoids

Phase 3 randomised study evaluating the addition of low-dose nivolumab to palliative chemotherapy in head and neck cancer

A Dominant Heterozygous Mutation in COG4 Causes Saul-Wilson Syndrome, a Primordial Dwarfism, and Disrupts Zebrafish Development via Wnt Signaling

The role of conserved transmembrane domain residues in the activation of the dopamine D2 receptor

Pikuni-Blackfeet traditional medicine: Neuroprotective activities of medicinal plants used to treat Parkinson’s disease-related symptoms

Aktive Filter

Suchergebnisse filtern